An innovative approach to the management of IOP in glaucoma.

Glaucoma is a group of progressive optic neuropathies that cause damage to the optic nerve and retinal ganglion cells. Elevated intraocular pressure (IOP) is a major factor in glaucoma, leading to axonal damage. While other risk factors may also play a role, IOP lowering strategies have been the main focus of treatment for over a century. However, a recent study published in the Journal suggests that VEGF-A treatment may increase outflow facility and vessel volume in the distal outflow tract, potentially offering a new approach to managing IOP in glaucoma. Further clinical studies are needed to confirm these findings. [Extracted from the article]